Dr. Glorioso is a physician-scientist and co-founder and CEO of NeuroAge Therapeutics, a longevity techbio company that is creating therapies and biomarkers for reprogramming brain aging. She was previously Head of AI of the Stanford spin-out, TeachAids, and Chief Strategist of the UCSF Bakar Aging Research Institute. Dr. Glorioso completed her postdoctoral training at MIT and holds an MD and PhD from the University of Pittsburgh and CMU Medical Scientist Training Program.